Drug Delivery Systems and Theranostic use in Nuclear Medicine

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.4274/nts.2015.018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy

  2015cited by this paper
• Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

  2015cited by this paper
• Nanogels from Metal-Chelating Crosslinkers as Versatile Platforms Applied to Copper-64 PET Imaging of Tumors and Metastases

  2015cited by this paper
• Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer

  2014cited by this paper
• Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle

  2014cited by this paper
• Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy

  2014cited by this paper
• Development of 111In-Labeled Liposomes for Vulnerable Atherosclerotic Plaque Imaging

  2014cited by this paper
• Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT

  2013cited by this paper
• Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging

  2013cited by this paper
• The Relation Between Perfusion Pattern of Hepatic Artery Perfusion Scintigraphy and Response to Y-90 Microsphere Therapy

  2013cited by this paper
• The use and importance of liposomes in Positron Emission Tomography

  2012cited by this paper
• Nanotechnology for neurodegenerative disorders.

  2012cited by this paper
• Liposomes and their applications in molecular imaging

  2012influential reference
• Theranostics: combining imaging and therapy.

  2011cited by this paper
• 64Cu loaded liposomes as positron emission tomography imaging agents.

  2011cited by this paper
• Nanotechnology and nuclear medicine; research and preclinical applications.

  2011cited by this paper
• Human Dosimetry and Preliminary Tumor Distribution of 18F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT

  2011cited by this paper
• Comparison of the stability of Y-90-, Lu-177- and Ga-68- labeled human serum albumin microspheres (DOTA-HSAM).

  2010cited by this paper
• Nanotechnology and radiopharmaceuticals: diagnostic and therapeutic approaches.

  2010cited by this paper
• Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

  2009cited by this paper
• Liposomal nanocarriers for tumor imaging.

  2009cited by this paper
• In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography.

  2009cited by this paper
• Radioactive liposomes.

  2009cited by this paper
• PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles

  2008cited by this paper
• 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas

  2008cited by this paper
• Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds

  2008cited by this paper
• Molecular imaging with nanoparticles: giant roles for dwarf actors

  2008cited by this paper
• Tumor Targeting with Antibody-Functionalized, Radiolabeled Carbon Nanotubes

  2007cited by this paper
• Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.

  2007cited by this paper
• Antinucleosome Antibody-Modified Liposomes and Lipid-Core Micelles for Tumor-Targeted Delivery of Therapeutic and Diagnostic Agents

  2007cited by this paper
• Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.

  2006cited by this paper
• The Nanotech Pioneers - Where Are They Taking Us?

  2006cited by this paper
• PET of vascular endothelial growth factor receptor expression.

  2006cited by this paper
• Nano-oncology: drug delivery, imaging, and sensing

  2006cited by this paper
• Multifunctional nanocarriers.

  2006cited by this paper
• Nanocarriers for nuclear imaging and radiotherapy of cancer.

  2006cited by this paper
• Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model.

  2005cited by this paper
• Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles

  2005cited by this paper
• The Preparation of Liposomes

  2005cited by this paper
• Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.

  2005cited by this paper
• Gold nanoshell bioconjugates for molecular imaging in living cells.

  2005cited by this paper
• Pathology: Cancer cells compress intratumour vessels

  2004cited by this paper
• Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy.

  2004cited by this paper
• Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.

  2004cited by this paper
• Radiolabeling of liposomes for scintigraphic imaging.

  2003cited by this paper
• Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation.

  2003cited by this paper
• Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

  2003cited by this paper
• Tumor Regression by Targeted Gene Delivery to the Neovasculature

  2002cited by this paper
• Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.

  2001cited by this paper
• Use of positron emission tomography in animal research.

  2001cited by this paper
• Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

  2001cited by this paper
• 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.

  2000cited by this paper
• Scintigraphic imaging of infections with 99m-Tc-labelled glutathione liposomes.

  2000cited by this paper
• Locoregional cancer treatment with magnetic drug targeting.

  2000cited by this paper
• Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.

  1999cited by this paper
• A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice.

  1997cited by this paper
• Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography.

  1996cited by this paper
• In vivo visualizing of organs and tissues with liposomes

  1995cited by this paper
• Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography.

  1995cited by this paper
• Use of technetium-99m-liposomes in tumor imaging.

  1994cited by this paper
• Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.

  1991cited by this paper
• Chemistry and biology of immunotargeted liposomes.

  1990cited by this paper
• Monoclonal antibody therapy of cancer.

  1990cited by this paper
• Liposomes as targetable drug carriers.

  1985cited by this paper
• Catabolism of desialylated ceruloplasmin in the liver.

  1970cited by this paper
• The action of steroids and streptolysin S on the permeability of phospholipid structures to cations.

  1965cited by this paper

• Recent developments in cancer therapy and diagnosis

  2020cites this paper
• Drug delivery nanosystems for neural regenerative medicine

  2020cites this paper